BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7545211)

  • 1. Detection of antibodies to L1, L2, and E4 proteins of human papillomavirus types 6, 11, and 16 by ELISA using synthetic peptides.
    Le Cann P; Chabaud M; Leboulleux D; Mougin C; Mayelo V; Legrand MC; Calvet C; Afoutou JM; Coll-Seck AM; Coursaget P
    J Med Virol; 1995 Apr; 45(4):410-4. PubMed ID: 7545211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan-HPV vaccine development.
    Khanal S; Ferraris ED; Zahin M; Joh J; Ghim SJ; Jenson AB
    Exp Mol Pathol; 2015 Oct; 99(2):330-4. PubMed ID: 26134615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies.
    Kawana K; Kawana Y; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
    Vaccine; 2001 Jan; 19(11-12):1496-502. PubMed ID: 11163673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase.
    Sehr P; Müller M; Höpfl R; Widschwendter A; Pawlita M
    J Virol Methods; 2002 Oct; 106(1):61-70. PubMed ID: 12367730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
    Kirnbauer R; Hubbert NL; Wheeler CM; Becker TM; Lowy DR; Schiller JT
    J Natl Cancer Inst; 1994 Apr; 86(7):494-9. PubMed ID: 8133532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa.
    Marais D; Rose RC; Williamson AL
    J Med Virol; 1997 Feb; 51(2):126-31. PubMed ID: 9021543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of peptide enzyme-linked immunosorbent assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins.
    Sun Y; Shah KV; Müller M; Muñoz N; Bosch XF; Viscidi RP
    J Clin Microbiol; 1994 Sep; 32(9):2216-20. PubMed ID: 7529250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2.
    Kawana K; Matsumoto K; Yoshikawa H; Taketani Y; Kawana T; Yoshiike K; Kanda T
    Virology; 1998 Jun; 245(2):353-9. PubMed ID: 9636375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.
    Christensen ND; Dillner J; Eklund C; Carter JJ; Wipf GC; Reed CA; Cladel NM; Galloway DA
    Virology; 1996 Sep; 223(1):174-84. PubMed ID: 8806551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Specific serologic studies with a novel authentic HPV antigen (virus-like particles) for HPV-6 antibodies in gynecologic patient samples].
    Heim K; Christensen ND; Höpfl R; Wartusch B; Zeimet A; Larcher C; Ruth N; Bergant A; Pirschner G; Dierich MP
    Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():25-31. PubMed ID: 8672922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus.
    Le Cann P; Touze A; Enogat N; Leboulleux D; Mougin C; Legrand MC; Calvet C; Afoutou JM; Coursaget P
    J Clin Microbiol; 1995 May; 33(5):1380-2. PubMed ID: 7615761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific.
    Kadish AS; Romney SL; Ledwidge R; Tindle R; Fernando GJ; Zee SY; Van Ranst MA; Burk RD
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2277-84. PubMed ID: 8077925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type-16 (HPV-16) in sera from patients with cervical intraepithelial neoplasia and children.
    Cason J; Kambo PK; Best JM; McCance DJ
    Int J Cancer; 1992 Feb; 50(3):349-55. PubMed ID: 1310487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata.
    Wikström A; Eklund C; Von Krogh G; Lidbrink P; Dillner J
    J Clin Microbiol; 1992 Jul; 30(7):1795-800. PubMed ID: 1378454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
    Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
    Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of human papillomavirus type 16 DNA and of antibodies to human papillomavirus type 16 proteins in children.
    Mund K; Han C; Daum R; Helfrich S; Müller M; Fisher SG; Schiller JT; Gissmann L
    Intervirology; 1997; 40(4):232-7. PubMed ID: 9612724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
    Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
    J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.
    Pouyanfard S; Spagnoli G; Bulli L; Balz K; Yang F; Odenwald C; Seitz H; Mariz FC; Bolchi A; Ottonello S; Müller M
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2.
    Seitz H; Schmitt M; Böhmer G; Kopp-Schneider A; Müller M
    Int J Cancer; 2013 Feb; 132(3):E139-48. PubMed ID: 22961598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.